Journal Information
Vol. 41. Issue 1.
Pages 2-4 (February 2005)
Vol. 41. Issue 1.
Pages 2-4 (February 2005)
Editorial
Full text access
¿Cuánto falta para la vacuna antinicotina?
Visits
8784
J.I. de Granda Orive
Servicio de Neumología. Hospital General Básico de la Defensa de Valencia. Valencia. España
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
K.F. Bonese, B.H. Wainer, F.W. Fitch, R.M. Rothberg, C.R. Shuster.
Changes in heroin self administration by rhesus monkey after morphine immunization.
Nature, 252 (1974), pp. 708-710
[2.]
A. Killian, K. Bonese, R.M. Rothberg, B.H. Wainer, C.R. Schuster.
Effects of passive immunization against morphine on heroin administration.
Pharmacol Biochem Behav, 9 (1978), pp. 347-352
[3.]
J.I. Granda Orive, S. Solano Reina, C.A. Jiménez Ruiz, T. Gutiérrez Jiménez, J.M. Martínez Albiach.
La vacuna antinicotina.
Otoneumoalergia Práctica, 12 (2003), pp. 20-24
[4.]
Granda Orive JI. El tabaquismo como enfermedad adictiva crónica. En: Jiménez Ruiz CA, Fagerström K, editores. Tratado de tabaquismo. Grupo Aula Médica. En prensa. 2004.
[5.]
M.R.A. Carrera, J.A. Ashley, L.H. Parsons, P. Wirsching, G.F. Koob, K.D. Janda.
Suppression of psychoactive effects of cocaine by active inmunization.
Nature, 378 (1995), pp. 727-730
[6.]
B.S. Fox, K.M. Kantak, M.A. Edwards, K.M. Black, B.K. Böllinger, A.J. Botka, et al.
Efficacy of a therapeutic cocaine vaccine in rodent models.
Nature Medicine, 2 (1996), pp. 1129-1132
[7.]
D.A. Keyler, Y. Hieda, J.S. Peter, P.R. Pentel.
Altered disposition of repeated nicotine doses in rats immunized against nicotine.
Nicotine Tob Res, 1 (1999), pp. 241-249
[8.]
Y. Hieda, D.E. Keyler, J.T. Vandervoort, J.K. Kane, C.A. Ross, D.E. Raphael, et al.
Active inmunization alters the plasma nicotine concentration in rats.
J Pharmacol Experimental Ther, 283 (1997), pp. 1076-1081
[9.]
Y. Hieda, D.E. Keyler, S. Ennifar, A. Fattom, P.R. Pentel.
Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain.
Int J Inmunopharmacol, 22 (2000), pp. 809-819
[10.]
P.R. Pentel, D.H. Malin, S. Ennifar, Y. Hieda, D.E. Keyler, J.R. Lake, et al.
A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats.
Pharmacol Biochem Behv, 65 (2000), pp. 191-198
[11.]
N. Lindblom, S.H.L. De Villiers, G. Kalayanov, S. Gordon, A.M. Johansson, T.H. Svensson.
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats.
Respiration, 69 (2002), pp. 254-260
[12.]
S.H.L. De Villiers, N. Lindhom, G. Kalayanov, S. Gordon, A. Malmerfelt, A.M. Johansson, et al.
Active immunization against nicotine-induced dopamine release in the rats nucleus accumbens shell.
Respiration, 69 (2002), pp. 247-253
[13.]
D.H. Malin, J.R. Lake, A. Lin, M. Saldana, L. Balch, M.L. Irvin, et al.
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
Pharmacol Biochem Behav, 68 (2001), pp. 87-92
[14.]
TA-NIC nicotine vaccine. Disponible en: www.xenova.co.uk/dc_ta_nic.html
[15.]
J.S. Clair Roberts, J. Dobson, D. Wood, M. Settles.
Safety and imnunogenicity of nicotine conjugate vaccine.
Proceedings of Annual Meeting of the College on Problems of Drug Dependence CPDD,
[16.]
J.S. Clair Roberts, C.V.R. Akers, L. Vanhinsbergh, K.A. McKenna, D.M. Wood, L. Jack, et al.
Longitudinal safety and inmunogenicity data of TA-NIC, a novel nicotine vaccine.
Proceedings of Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT),
[17.]
K. Lindmayer, G. Horwith, A. Fattom, R. Naso, S. Fuller, L. Muenz, et al.
Results of a phase 1, double blinded, controlled safety and inmunogenicity trial of NICVAX™, a conjugated nicotine vaccine.
Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT),
[18.]
K. Lindmayer, G. Horwith, A. Fattom, R. Naso, S. Fuller, L. Muenz, et al.
Results of a phase 1, double blinded, controlled safety and inmunogenicity trial of NICVAXTM, a conjugated nicotine vaccine.
Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT);,
[19.]
C.J. Bunce, P.T. Loudon, C. Akers, J. Dobson, D.M. Wood.
Development of vaccines to help treat drug dependence.
Curr Opin Mol Ther, 5 (2003), pp. 58-63
[20.]
S.D. Satoskar, D.E. Keyler, M.G. Le Sage, D.E. Raphael, C. Ross, P.R. Pentel.
Tissue dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats.
Int Immunopharmacol, 3 (2003), pp. 957-970
[21.]
P. Pentel, D. Malin.
A vaccine for nicotine dependence: targeting the drug rather than the brain.
Respiration, 69 (2002), pp. 193-197
[22.]
E.H. Cerny, R. Lévy, J. Mauel, M. Mpandi, M. Mutter, C. Henzelin-Nkubana, et al.
Preclinical development of a vaccine against smoking.
Onkologie, 25 (2002), pp. 406-411
[23.]
S.D. Sanderson, S.R. Cheruku, M.P. Padmanilayam, J.L. Vennerstrom, G.M. Thiele, M.I. Palmatier, et al.
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant.
Int Immunopharmacol, 3 (2003), pp. 137-146
[24.]
M.R.A. Carrera, J.A. Ashley, T.Z. Hoffman, S. Isomura, P. Wirsching, G.F. Koob, et al.
Investigation using immunization to attenuate the psychoactive effects of nicotine.
Bioorg Med Chem, 12 (2004), pp. 563-570
[25.]
E.M. Sellers, H.L. Kaplan, R.F. Tyndale.
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Clin Pharmacol Ther, 68 (2000), pp. 35-43
[26.]
M.M. Meijler, M. Matsushita, L.J. Altobell, P. Wirsching, K.D. Janda.
A new strategy for improved nicotine vaccines using conformationally constrained haptens.
J Am Chem Soc, 125 (2003), pp. 7164-7165
[27.]
Respiratory Reviews.com. New approaches to smoking cessation show promise. Disponible en: http://www.respiratoryreviews.com/mar01/rr_cessation.html
[28.]
W. Hall.
The prospects for immunotherapy in smoking cessation.
Lancet, 360 (2002), pp. 1089-1091
[29.]
F.J. Vocci, C.N. Chiang.
Vaccines against nicotine: how effective are they likely to be in preventing smoking?.
CNS Drugs, 15 (2001), pp. 505-514
[30.]
D.E. Keyler, D. Shoeman, M.G. Lessge, A.D. Calvin, P.R. Pentel.
Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats.
J Pharmacol Exp Ther, 305 (2003), pp. 587-592
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?